321 related articles for article (PubMed ID: 16530171)
1. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin test.
Ulker E; Toma W; White A; Uprety R; Majumdar S; Damaj MI
Behav Pharmacol; 2020 Apr; 31(2&3):174-178. PubMed ID: 32168026
[TBL] [Abstract][Full Text] [Related]
3. Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents.
Morales L; Perez-Garcia C; Alguacil LF
Br J Pharmacol; 2001 May; 133(1):172-8. PubMed ID: 11325807
[TBL] [Abstract][Full Text] [Related]
4. Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia.
Lunzer MM; Yekkirala A; Hebbel RP; Portoghese PS
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6061-5. PubMed ID: 17389363
[TBL] [Abstract][Full Text] [Related]
5. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.
Daniels DJ; Lenard NR; Etienne CL; Law PY; Roerig SC; Portoghese PS
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19208-13. PubMed ID: 16365317
[TBL] [Abstract][Full Text] [Related]
6. Role of the guanine nucleotide binding protein, Gα
Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.
Kopruszinski CM; Swiokla J; Lee YS; Navratilova E; VanderVeen L; Yang M; Liu Y; Miyazaki T; Schmidt WK; Zalevsky J; Porreca F
Cell Mol Neurobiol; 2021 Jul; 41(5):949-960. PubMed ID: 32107752
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between Human Spinal Cord μ-opioid Receptor 1Y Isoform and Gastrin-releasing Peptide Receptor Mediates Opioid-induced Scratching Behavior.
Liu XY; Ginosar Y; Yazdi J; Hincker A; Chen ZF
Anesthesiology; 2019 Aug; 131(2):381-391. PubMed ID: 31314749
[TBL] [Abstract][Full Text] [Related]
9. Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice.
Matsumoto K; Narita M; Muramatsu N; Nakayama T; Misawa K; Kitajima M; Tashima K; Devi LA; Suzuki T; Takayama H; Horie S
J Pharmacol Exp Ther; 2014 Mar; 348(3):383-92. PubMed ID: 24345467
[TBL] [Abstract][Full Text] [Related]
10. Involvement of spinal cord opioid mechanisms in the acute antinociceptive effect of hyperbaric oxygen in mice.
Heeman JH; Zhang Y; Shirachi DY; Quock RM
Brain Res; 2013 Dec; 1540():42-7. PubMed ID: 24113418
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.
Dietis N; Niwa H; Tose R; McDonald J; Ruggieri V; Filaferro M; Vitale G; Micheli L; Ghelardini C; Salvadori S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
Br J Pharmacol; 2018 Jul; 175(14):2881-2896. PubMed ID: 29524334
[TBL] [Abstract][Full Text] [Related]
12. The Role of Opioid Receptor Antagonists in Regulation of Blood Pressure and T-Cell Activation in Mice Selected for High Analgesia Induced by Swim Stress.
Skiba D; Jaskuła K; Nawrocka A; Poznański P; Łazarczyk M; Szymański Ł; Żera T; Sacharczuk M; Cudnoch-Jędrzejewska A; Gaciong Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473865
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.
Zheng Y; Obeng S; Reinecke BA; Chen C; Phansalkar PS; Walentiny DM; Gerk PM; Liu-Chen LY; Selley DE; Beardsley PM; Zhang Y
Eur J Pharmacol; 2019 Dec; 865():172812. PubMed ID: 31743739
[TBL] [Abstract][Full Text] [Related]
14. Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
Hutchinson MR; Zhang Y; Shridhar M; Evans JH; Buchanan MM; Zhao TX; Slivka PF; Coats BD; Rezvani N; Wieseler J; Hughes TS; Landgraf KE; Chan S; Fong S; Phipps S; Falke JJ; Leinwand LA; Maier SF; Yin H; Rice KC; Watkins LR
Brain Behav Immun; 2010 Jan; 24(1):83-95. PubMed ID: 19679181
[TBL] [Abstract][Full Text] [Related]
15. Coincident Regulation of PLC
Sanchez GA; Jutkiewicz EM; Ingram S; Smrcka AV
Mol Pharmacol; 2022 Dec; 102(6):269-279. PubMed ID: 36116788
[TBL] [Abstract][Full Text] [Related]
16. Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.
Ben Haddou T; Malfacini D; Calo G; Aceto MD; Harris LS; Traynor JR; Coop A; Schmidhammer H; Spetea M
Mol Pain; 2014 Jul; 10():48. PubMed ID: 25059282
[TBL] [Abstract][Full Text] [Related]
17. G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.
Terman GW; Jin W; Cheong YP; Lowe J; Caron MG; Lefkowitz RJ; Chavkin C
Br J Pharmacol; 2004 Jan; 141(1):55-64. PubMed ID: 14662727
[TBL] [Abstract][Full Text] [Related]
18. Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.
Le Naour M; Lunzer MM; Powers MD; Portoghese PS
J Med Chem; 2012 Jan; 55(2):670-7. PubMed ID: 22136373
[TBL] [Abstract][Full Text] [Related]
19. Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain.
Nation KM; De Felice M; Hernandez PI; Dodick DW; Neugebauer V; Navratilova E; Porreca F
Pain; 2018 May; 159(5):919-928. PubMed ID: 29369967
[TBL] [Abstract][Full Text] [Related]
20. Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala.
Maire JJ; Close LN; Heinricher MM; Selden NR
Eur J Pain; 2016 Feb; 20(2):206-14. PubMed ID: 25847835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]